• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Attention Deficit Disorder with Hyperactivity

Attention Deficit Disorder with Hyperactivity - 737 Studies Found

Completed : A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
: Attention-Deficit Hyperactivity Disorder
: 2013-06-21
:
  • Drug: HLD100-B d-amphetamine s

Completed : Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
: Attention-deficit/Hyperactivity Disorder
: 2010-03-03
:
  • Drug: Extended-release Guanfacine Hydrochloride

Completed : A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder
: Attention Deficit/ Hyperactivity Disorder
: 2008-07-10
:
  • Drug: prolonged release (PR) OROS methylphenidate 54 mg

Completed : Long Duration Stimulant Treatment Study of Preschoolers With ADHD-Feasibility Study
: Attention Deficit Disorder With Hyperactivity
: 2005-11-21
: Drug: Ritalin LA™
Completed : Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
: Attention-Deficit/Hyperactivity Disorder
: 2010-03-03
:
  • Drug: Extended-release Guanfacine Hydrochloride

Completed : Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2012-02-23
: Behavioral: IBBS Combination of computer-presented brain exercises with a physical education curriculum
Completed : Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2014-05-14
:
  • Behavioral: Academic and Organization skills

Completed : Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate
: Attention-Deficit/Hyperactivity Disorder
: 2010-04-14
:
  • Drug: Lisdexamfetamine Dimesylate

Completed : Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)
: Attention-Deficit/Hyperactivity Disorder
: 2009-10-19
:
  • Drug: extended-release guanfacine hydrochloride (SPD503)

Completed : Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Hyperactivity Disorder (ADHD)
: 2015-03-27
: Other: Behavioral assessment and NAT EEG tests Individuals in both groups are asked to perform standard
<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.